pharmaphorum

JULY 7, 2022

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Read on to find out about reaching the gold standard of lung cancer screening, the promise of therapeutic cancer vaccines, why diversity is essential in oncology trials, and much more.

Healthcare Provider 52

Healthcare Provider Physicians Healthcare Healthcare 52

pharmaphorum

JULY 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide.

Training 52

Training Patients 52

pharmaphorum

AUGUST 18, 2022

Last month in Chicago, Illinois the American Society of Clinical Oncology hosted its first in-person meeting since the COVID-19 pandemic began. Led by Merck’s blockbuster Keytruda, these drugs have been making waves in the oncology space for some time, and this year’s ASCO kept up that trend.

Patients 52

Patients 52

pharmaphorum

OCTOBER 6, 2022

Many of these challenges are exacerbated in oncology, where the treatment landscape rapidly evolves with novel mechanisms of actions (e.g., Strategic planning and early investments in HCP and patient education are critical success factors for small and emerging companies launching oncology products.

Education 52

Education Healthcare Provider Physicians Competition 52

pharmaphorum

DECEMBER 2, 2022

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Unlocking the promise of patient support programmes in oncology. Read Deep Dive: Digital Health 2022 in full.

Healthcare 52

Healthcare Healthcare Pharma Marketing 52

pharmaphorum

SEPTEMBER 22, 2022

Read on to find out about unlocking the potential of connected commercialisation solutions, what HCPs want from post-pandemic communication, achieving launch excellence in oncology and much more. Achieving launch excellence in oncology. A successful launch in the oncology space is not guaranteed; it is strategically planned and earned.

Pharma 52

Pharma Marketing Pharmaceutical Physicians 52

pharmaphorum

AUGUST 4, 2022

Over the past two decades, innovative research efforts, such as the Human Genome Project and 100,000 Genomes Project, have vastly expanded our understanding of the human genome and its role in driving research and development in oncology. The post Realising the promise of genomic testing across oncology appeared first on.

Marketing 52

Marketing Patients 52